Michel Burnier


Ontology type: schema:Person     


Person Info

NAME

Michel

SURNAME

Burnier

Publications in SciGraph latest 50 shown

  • 2018-06 Update on Endothelin Receptor Antagonists in Hypertension in CURRENT HYPERTENSION REPORTS
  • 2018 Taxonomy of Medication Adherence: Recent Developments in DRUG ADHERENCE IN HYPERTENSION AND CARDIOVASCULAR PROTECTION
  • 2018 Qualitative Assessments of Adherence in DRUG ADHERENCE IN HYPERTENSION AND CARDIOVASCULAR PROTECTION
  • 2017-12 A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges in BMC NEPHROLOGY
  • 2017-01 Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-12 Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population in NUTRITION & METABOLISM
  • 2016-01 Feasibility, Acceptability, and Preliminary Effects of Educational Intervention to Strengthen Humanistic Practice Among Hemodialysis Nurses in the Canton of Vaud, Switzerland: A Pilot Study in INTERNATIONAL JOURNAL FOR HUMAN CARING
  • 2015-12 ENaC activity in collecting ducts modulates NCC in cirrhotic mice in PFLÜGERS ARCHIV - EUROPEAN JOURNAL OF PHYSIOLOGY
  • 2015-07 Antihypertensive Combination Treatment: State of the Art in CURRENT HYPERTENSION REPORTS
  • 2014-03 Blood pressure changes after renal denervation at 10 European expert centers in JOURNAL OF HUMAN HYPERTENSION
  • 2013-11 Discovery and refinement of loci associated with lipid levels in NATURE GENETICS
  • 2013-10 Blockade of the Renin-Angiotensin System in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis in CURRENT HYPERTENSION REPORTS
  • 2010-08 Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals in DIABETOLOGIA
  • 2009-02 Vascular Effects of RWJ‐676070, a Selective Combined V1a/V2 Vasopressin Receptor Antagonist in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2008-12 Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland in BMC NEPHROLOGY
  • 2006-12 Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients in BMC NEPHROLOGY
  • 2006-06 Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective in CARDIOVASCULAR DRUGS AND THERAPY
  • 2005-12 Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey in BMC CARDIOVASCULAR DISORDERS
  • 2005-01 Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean) in KIDNEY INTERNATIONAL
  • 2003-10 Renal hemodynamic and tubular responses to salt in women using oral contraceptives in KIDNEY INTERNATIONAL
  • 2002-02 Renal segmental tubular response to salt during the normal menstrual cycle in KIDNEY INTERNATIONAL
  • 2002-01 Comparative angiotensin II receptor blockade in healthy volunteers: The importance of dosing in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2002-01 Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries in INTERNATIONAL JOURNAL OF OBESITY
  • 2000-10 Electronic Monitoring of Long-Term use of Nicotine Nasal Spray in Former Smokers in JOURNAL OF GENERAL INTERNAL MEDICINE
  • 2000-10 Electronic Monitoring of Long-Term use of Nicotine Nasal Spray in Former Smokers in JOURNAL OF GENERAL INTERNAL MEDICINE
  • 1998 Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects in KIDNEY INTERNATIONAL
  • 1994-07 A device for subjecting vascular endothelial cells to both fluid shear stress and circumferential cyclic stretch in ANNALS OF BIOMEDICAL ENGINEERING
  • 1991 Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1981-05 Three new long‐acting converting‐enzyme inhibitors: Relationship between plasma converting‐enzyme activity and response to angiotensin I in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.8515.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.50550.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9851.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413958.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7400.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414250.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5734.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411656.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.150338.c", 
            "type": "Organization"
          }
        ], 
        "familyName": "Burnier", 
        "givenName": "Michel", 
        "id": "sg:person.01200222171.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200222171.20"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_539.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01200222171.20'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01200222171.20'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01200222171.20'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01200222171.20'


     

    This table displays all metadata directly associated to this object as RDF triples.

    36 TRIPLES      10 PREDICATES      21 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01200222171.20 schema:affiliation Nf531c0c7d7fb46ae8f94490c894c8c7e
    2 https://www.grid.ac/institutes/grid.150338.c
    3 https://www.grid.ac/institutes/grid.21107.35
    4 https://www.grid.ac/institutes/grid.411656.1
    5 https://www.grid.ac/institutes/grid.413958.2
    6 https://www.grid.ac/institutes/grid.414250.6
    7 https://www.grid.ac/institutes/grid.48769.34
    8 https://www.grid.ac/institutes/grid.50550.35
    9 https://www.grid.ac/institutes/grid.5734.5
    10 https://www.grid.ac/institutes/grid.7400.3
    11 https://www.grid.ac/institutes/grid.9851.5
    12 schema:familyName Burnier
    13 schema:givenName Michel
    14 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200222171.20
    15 schema:sdDatePublished 2019-03-07T14:48
    16 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    17 schema:sdPublisher Nf22e3ed937be4fabaea811a315fd5731
    18 sgo:license sg:explorer/license/
    19 sgo:sdDataset persons
    20 rdf:type schema:Person
    21 Nf22e3ed937be4fabaea811a315fd5731 schema:name Springer Nature - SN SciGraph project
    22 rdf:type schema:Organization
    23 Nf531c0c7d7fb46ae8f94490c894c8c7e schema:affiliation https://www.grid.ac/institutes/grid.8515.9
    24 sgo:isCurrent true
    25 rdf:type schema:OrganizationRole
    26 https://www.grid.ac/institutes/grid.150338.c schema:Organization
    27 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    28 https://www.grid.ac/institutes/grid.411656.1 schema:Organization
    29 https://www.grid.ac/institutes/grid.413958.2 schema:Organization
    30 https://www.grid.ac/institutes/grid.414250.6 schema:Organization
    31 https://www.grid.ac/institutes/grid.48769.34 schema:Organization
    32 https://www.grid.ac/institutes/grid.50550.35 schema:Organization
    33 https://www.grid.ac/institutes/grid.5734.5 schema:Organization
    34 https://www.grid.ac/institutes/grid.7400.3 schema:Organization
    35 https://www.grid.ac/institutes/grid.8515.9 schema:Organization
    36 https://www.grid.ac/institutes/grid.9851.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...